Helix Biotech, Inc.
The startup develops protein-based nanoparticles for high-yield encapsulation of nucleic acids, small molecules, and proteins, utilizing lipid nanoparticles, liposomes, emulsions, polymers, and dendrimers. This technology enables pharmaceutical companies to enhance drug delivery systems by improving the stability and bioavailability of their therapeutics.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$300KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops protein-based nanoparticles for high-yield encapsulation of nucleic acids, small molecules, and proteins, utilizing lipid nanoparticles, liposomes, emulsions, polymers, and dendrimers. This technology enables pharmaceutical companies to enhance drug delivery systems by improving the stability and bioavailability of their therapeutics.